Rheumatology

How to Accelerate Lupus Solutions with RWD, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, December 4, 2023

TORONTO, Dec. 4, 2023 /PRNewswire-PRWeb/ -- Join this informative webinar to explore lupus solutions and real-world treatment impacts through a discussion on patient aspects and the role of technology in streamlining research efficiency. Lupus is a complex disease with diverse manifestations, limited treatment options and inequitable impact on the affected population. This makes research into patient experience, treatment patterns and long-term clinical outcomes particularly challenging.

Key Points: 
  • In this free webinar, explore lupus solutions and real-world treatment impacts through a discussion on patient aspects and the role of technology in streamlining research efficiency.
  • Attendees will gain insights into key patient-relevant features that should be covered by real-world data (RWD) in lupus.
  • TORONTO, Dec. 4, 2023 /PRNewswire-PRWeb/ -- Join this informative webinar to explore lupus solutions and real-world treatment impacts through a discussion on patient aspects and the role of technology in streamlining research efficiency.
  • Lupus is a complex disease with diverse manifestations, limited treatment options and inequitable impact on the affected population.

Clarius Awarded Technology Breakthrough Designation in Ultrasound Category with Premier, Inc.

Retrieved on: 
Friday, December 1, 2023

VANCOUVER, BC, Dec. 1, 2023 /PRNewswire/ -- Clarius Mobile Health has been awarded a Technology Breakthrough Designation in the Ultrasound contract category with Premier, Inc. Effective December 1, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Clarius technology.

Key Points: 
  • VANCOUVER, BC, Dec. 1, 2023 /PRNewswire/ -- Clarius Mobile Health has been awarded a Technology Breakthrough Designation in the Ultrasound contract category with Premier, Inc.
  • Premier offers Breakthrough Technology designations to innovations that offer a major advantage in terms of patient safety, clinical outcomes, and operational efficiencies.
  • Clarius proved to provide these benefits to Premier members with their broad range of specialty-focused ultrasound scanners, market-leading AI applications, and best-in-class image quality.
  • "Being awarded Premier's Technology Breakthrough is an important step towards achieving our mission to put accurate, easy-to-use, and affordable ultrasound into the hands of every clinician," says Clarius President and Chief Executive Officer Ohad Arazi.

Asheville Arthritis & Osteoporosis Center Partners with House Rx to Enhance Patient Care Through Medically Integrated Dispensing

Retrieved on: 
Friday, December 1, 2023

ASHEVILLE, N.C., Nov. 30, 2023 /PRNewswire-PRWeb/ -- House Rx, the platform for medically integrated dispensing of specialty medications, today announced a partnership with Asheville Arthritis & Osteoporosis Center ("Asheville Arthritis"), an independent rheumatology practice located in Asheville, NC, that will bring on-site specialty medication dispensing to its patients.

Key Points: 
  • Asheville Arthritis & Osteoporosis Center, a community rheumatology clinic based in North Carolina, will be adopting a new care model aimed at improving patient access to life-improving specialty medications.
  • Medically integrated dispensing ensures treatments are closely managed, which is critical for the outcomes of patients with chronic, progressive and painful rheumatic diseases
    ASHEVILLE, N.C., Nov. 30, 2023 /PRNewswire-PRWeb/ -- House Rx , the platform for medically integrated dispensing of specialty medications, today announced a partnership with Asheville Arthritis & Osteoporosis Center ("Asheville Arthritis"), an independent rheumatology practice located in Asheville, NC, that will bring on-site specialty medication dispensing to its patients.
  • "With the increasing number of patient-administered therapies used to treat autoimmune diseases, we believe medically integrated dispensing is essential to the future of rheumatology care," said Dr. Ellison Smith, at Asheville Arthritis & Osteoporosis Center.
  • "With the increasing number of patient-administered therapies used to treat autoimmune diseases, we believe medically integrated dispensing is essential to the future of rheumatology care," said Dr. Ellison Smith, at Asheville Arthritis & Osteoporosis Center.

7,700 Resident Physicians Placed into Fellowship Training Positions through the NRMP's Medicine and Pediatric Specialties Match

Retrieved on: 
Wednesday, November 29, 2023

WASHINGTON, Nov. 29, 2023 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) has released results for the 2023 Medicine and Pediatric Specialties Match, its largest fellowship Match encompassing 38 subspecialties. The 2023 Match featured an all-time high of 3,482 programs that certified a rank order list, marking a 3.6 percent increase in the number of programs over 2022. These programs collectively offered 9,068 positions, a 3.9 percent increase with 344 more positions than the previous year. Of these positions, 7,723 (85.2 percent) were filled when the matching algorithm was processed. While both the number of programs and positions increased by over three percent, the number of applicants certifying a rank order list for the Match saw a modest rise of only 35 applicants or 0.4 percent.

Key Points: 
  • WASHINGTON, Nov. 29, 2023 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) has released results for the 2023 Medicine and Pediatric Specialties Match, its largest fellowship Match encompassing 38 subspecialties.
  • "The growth of fellowship programs and positions in the Match reflect training opportunities and the future workforce trends of medical subspecialties.
  • Pediatric specialties offered 1,878 certified positions, filling 1,487 positions (79.2 percent), a decrease of 5.5 percent compared to last year.
  • Pediatric specialties filling over ninety-five percent of their positions include Pediatric Cardiology and Pediatric Hospital Medicine.

Patient Affordability and Access to Specialty and Biologic Medications Just Got Easier

Retrieved on: 
Tuesday, November 28, 2023

CRANBERRY TOWNSHIP, Pa., Nov. 28, 2023 /PRNewswire/ -- Annexus Health, Inc., the leading healthcare technology company that is revolutionizing the patient access journey through its innovative solutions, today announced a strategic partnership with WeInfuse, the premier technology and consulting provider for infusion therapy and medication delivery in the United States.

Key Points: 
  • AssistPoint is a comprehensive patient financial assistance management solution for infusion centers, community practices, multispecialty providers, hospitals, institutions, and specialty pharmacies.
  • The Adparo team utilizes AssistPoint to identify, enroll patients in, and manage financial assistance and other access services.
  • "Proactively managing patient financial assistance is imperative to infusion centers, and our suite of products and services empowers them to do that," said Annexus Health Co-Founder and President Brad Frazier.
  • "By partnering with Annexus Health, we can now offer our clients powerful, customizable solutions to streamline and automate the patient financial assistance process to make infusion therapy more accessible and affordable."

HSS Presents New Reproductive Health Research at the ACR Convergence 2023

Retrieved on: 
Tuesday, November 14, 2023

Additional research is planned to assess whether demographics, lifestyle and medical conditions may influence this potential association.

Key Points: 
  • Additional research is planned to assess whether demographics, lifestyle and medical conditions may influence this potential association.
  • This study surveyed women of reproductive age with systemic rheumatic disease about their use of contraceptives.
  • Data were collected on 249 women with reproductive capacity, including 147 with inflammatory arthritis and 102 with lupus-like disorders.
  • This study used data from the electronic health record of patients diagnosed with a rheumatic disease in adolescence, seen at HSS, to look at factors associated with HPV vaccination.

Hospital for Special Surgery and NCH Break Ground on New Orthopedics Center of Excellence in Southwest Florida

Retrieved on: 
Monday, November 13, 2023

Located on the campus of the NCH North Naples Hospital, the center promises to bring unparalleled orthopedic care to Naples and Southwest Florida.

Key Points: 
  • Located on the campus of the NCH North Naples Hospital, the center promises to bring unparalleled orthopedic care to Naples and Southwest Florida.
  • The center will offer outpatient and inpatient orthopedic services, including an ambulatory surgery center and imaging and rehabilitation services that will be jointly owned and operated with HSS.
  • HSS has been recognized as a top-ranked hospital for both orthopedics and rheumatology for 31 consecutive years, ranking no.
  • For more information on how you can support HSS at NCH and be part of this historic partnership, please contact the NCH Center for Philanthropy at 239-624-2000.

Study Finds People with Inflammatory Arthritis Face Significant Psychological Challenges in Maintaining Employment

Retrieved on: 
Monday, November 13, 2023

SAN DIEGO, Nov. 13, 2023 /PRNewswire/ -- Research from Hospital for Special Surgery (HSS) reveals a significant psychological impact related to inflammatory arthritis patients' efforts to maintain employment while coping with the challenges of their illness.

Key Points: 
  • SAN DIEGO, Nov. 13, 2023 /PRNewswire/ -- Research from Hospital for Special Surgery (HSS) reveals a significant psychological impact related to inflammatory arthritis patients' efforts to maintain employment while coping with the challenges of their illness.
  • The study, titled "The Psychological Experience of Work for People with Inflammatory Arthritis (IA)," was presented at the American College of Rheumatology (ACR) Convergence 2023 on November 13 in San Diego.
  • "While previous studies have described challenges in maintaining employment, they have largely focused on addressing concrete barriers and strategies.
  • The study findings reveal key psychosocial areas to consider in a comprehensive health assessment of patients with inflammatory arthritis, Westreich said.

A High-Risk Antiphospholipid Antibody Profile Matters in Pediatric Patients with Antiphospholipid Syndrome

Retrieved on: 
Sunday, November 12, 2023

SAN DIEGO, Nov. 12, 2023 /PRNewswire/ -- A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients.

Key Points: 
  • SAN DIEGO, Nov. 12, 2023 /PRNewswire/ -- A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients.
  • "Our study reveals that an initial high-risk antiphospholipid antibody profile is unlikely to be transient in pediatric patients, indicating their risk of serious health problems remains elevated and they should be followed carefully."
  • For patients with symptoms, rheumatologists use three laboratory tests to evaluate the presence of aPL: lupus anticoagulant (LA), anticardiolipin antibody (aCL) and anti-beta-2-glycoprotein-1 antibody (aβ2GPI).
  • "An international effort has been initiated to pool pediatric APS data and ultimately guide the development of classification criteria for pediatric patients."

Lupus Foundation of America Awards Scientists for Notable Contributions to Lupus Research

Retrieved on: 
Sunday, November 12, 2023

WASHINGTON, Nov. 12, 2023 /PRNewswire/ -- The Lupus Foundation of America (LFA) is pleased to recognize two leading lupus researchers at the 2023 Evelyn V. Hess Reception.

Key Points: 
  • WASHINGTON, Nov. 12, 2023 /PRNewswire/ -- The Lupus Foundation of America (LFA) is pleased to recognize two leading lupus researchers at the 2023 Evelyn V. Hess Reception.
  • She is the current chair of LuCIN, a network of academic institutions collaborating in the conduct of lupus clinical trials.
  • "As a practicing rheumatologist, I am passionate about lupus research because I see firsthand how this disease disproportionately impacts historically vulnerable communities.
  • Dr. Choi was funded by several career development awards including the Lupus Foundation of America Gary S. Gilkeson Career Development Award, during which she was supervised by her mentor, Dr. Karen Costenbader.